Company Data
| Last traded |
R100.60 |
| Change |
R-0.57 |
| % Change |
-0.56% |
| Cumulative volume |
779,310 |
| Market cap |
R43.92bn |
Related Articles
Top Stories
Feb 12 2012 15:59
Moral hazard, financial weapons of mass destruction, a huge mess - these were the words used by a founder member to sum up the collapse of the Pinnacle Point Group.
Feb 12 2012 15:58
Construction companies are now undertaking a second round of self-examination into uncompetitive behaviour.
Feb 12 2012 14:54
American billionaire George Soros has slammed German Chancellor Angela Merkel, warning that her policies could lead to a repeat of the Great Depression.
Johannesburg - Pharmaceutical group Aspen Pharmacare Holdings [JSE:APN] on Wednesday reported a 31% rise in after tax profit for the interim period to end-December.
The group's revenue grew by 10% to R4.576bn, while headline earnings per share from continuing operations increased 27% to 242.3 cents.
The group said its South African business maintained its leadership position across the private and public sectors of the pharmaceutical market and grew revenue by 23% to R2.55bn, while revenue from offshore operations increased by 12% to R1.797bn.
Aspen CEO Stephen Saad said "the excellent performance" recorded by the South African operations was driven by robust volume growth and margin improvements.
"Revenue growth in the international business is attributed to gains from global brands, the Asia Pacific domestic brands, the oncology business and from the GlaxoSmithKline (GSK) transactions."
- Fin24.com